Indegene share price jumps 5% to hit a 52-week high after Axis initiates coverage with a buy
60-Word AI Digest
Indegene's share price soared after Axis Direct initiated coverage with a 'buy' recommendation, suggesting an 18% upside. The company's blend of biopharma expertise and AI solutions positions it well for future growth, as per the brokerage firm.
Key Takeaways
- Indegene's share price soared after Axis Direct initiated coverage with a 'buy' recommendation, suggesting an 18% upside.
- The company's blend of biopharma expertise and AI solutions positions it well for future growth, as per the brokerage firm.
- Full details and original dispatch available below.
Indegene's share price soared after Axis Direct initiated coverage with a 'buy' recommendation, suggesting an 18% upside. The company's blend of biopharma expertise and AI solutions positions it well for future growth, as per the brokerage firm.
Original Publisher Attribution
This summary was curated from Check target price.